Bill Sibold Salary and Compensation - MADRIGAL PHARMACEUTICALS, INC. CEO Pay 2025

In fiscal year 2025, Bill Sibold, President and Chief Executive Officer of MADRIGAL PHARMACEUTICALS, INC. (MDGL), received total compensation of $19.2 million.

Bill Sibold's compensation breakdown includes: base salary of $919K, stock awards valued at $12.3 million, option awards of $4.5 million, non-equity incentive compensation of $1.4 million, and other compensation of $14K.

Compared to fiscal year 2024, Bill Sibold's total compensation increased 57% from $12.2 million to $19.2 million.

MADRIGAL PHARMACEUTICALS, INC. (MDGL) Executive Pay 2025

MADRIGAL PHARMACEUTICALS, INC.'s top 6 named executive officers received combined total compensation of $52.0 million in fiscal year 2025.

The named executive officers disclosed in MADRIGAL PHARMACEUTICALS, INC.'s 2025 proxy statement are:Bill Sibold (President and Chief Executive Officer) with total compensation of $19.2 million, David Soergel (M.D. Executive Vice President and Chief Medical Officer) with total compensation of $9.2 million, Rebecca Taub (M.D. Senior Scientific and Medical Advisor and Former President, Research & Development and Chief Medical Officer) with total compensation of $6.9 million, Mardi Dier (Executive Vice President and Chief Financial Officer) with total compensation of $6.1 million, Carole Huntsman (Executive Vice President and Chief Commercial Officer) with total compensation of $5.4 million, and Shannon Kelley (Executive Vice President and Chief Legal Counsel) with total compensation of $5.2 million.